CDC authorizes Moderna’s COVID-19 vaccine

 for use in children 6 through 17 Years

June 24, 2022

The CDC’s Advisory Committee on Immunization Practices’ (ACIP) has now authorized Moderna’s COVID-19 vaccine to be used as an option for children ages 6 through 17 years, in addition to its already recommended use in children 6 months through 5 years and adults 18 years and older.

With this authorization it is important to highlight a few very important details as we move forward with this vaccine roll-out:

• Vaccine vials specifically labeled for the age group 6 years through 11 years of age are not  available.
• The Moderna COVID-19 vaccine vial labeled “BOOSTER DOSES ONLY” (aka Moderna 5) has been authorized to provide primary series doses (0.5 mL each) for individuals 6 through 11 years of age, AND as a booster dose for individuals 18 years of age and older*.
• This presentation of the Moderna COVID-19 Vaccine is supplied as multiple-dose vials with dark blue caps and labels with a purple border [NDC 80777-275-05].

Vial Presentation Available to Provide Doses for Ages 6 Years through 11 Years

* BOOSTER DOSES of this presentation are ONLY authorized to be given to those 18 years of age and older and may not be given to individuals 6 – 11 years of age (only to be given as primary series).

For all Moderna COVID-19 Presentations:

* Teal cap vaccine vials specifically labeled for the age group 6 years through 11 years of      age are NOT available.  

Additional resources:

• Vial Wall Chart – Moderna COVID-19 Vaccine Presentations
• What to Expect HCP Letter – Moderna Peds COVID-19 Vaccine
• Video – Dosing and Administration of Moderna Peds COVID-19 Vaccine
• Administration of Moderna COVID-19 Vaccines

Please check weblinks frequently for new content – CDC is continuing to update materials with the newest recommendations.

The CDC will also be hosting a special post-ACIP call on Monday, June 27^th, from 2:00 – 3:00 ET.

The agenda is as follows:

1. Welcome and Introductions
2. Recap of ACIP Recommendations
3. Clinical Considerations
4. Vaccine Ordering and Distribution
5. Updates on code sets
6. Q & A

If you have any questions, please contact the Maine Immunization Program at (207) 287-3746 or email: ImmunizeME.DHHS@maine.gov.

Thank you for your continued efforts to ensure that all Mainers have access to COVID-19 vaccination.